Evidence in Crohn's disease, hints why LDN works in the 2006 Report of Medline, the researchers noted that Crohn's disease seems to be associated with weak immune systems, not overactive one. In 2002 in his book, autoimmune diseases and their environmental triggers I have described as characteristic of the immune system lasix 180 mg is weak in autoimmune diseases. This weakness, which has long been recognized in alternative medicine circles, causing white blood cells respond properly, over-react to their own agenda in the body. Understanding the mechanism of this view is prevalent in oriental medicine and has been confirmed by laboratory tests many times. The fact that the new report does not seem to understand that a strong immune system and hyperactive immune system is not the same as does the lack of progress in the field of autoimmune diseases in disbelief. Immune system, when working as it should, strong and able to protect the body from foreign organisms. If it is weak, cellular activity is random in nature and their own body proteins are recognized as if they were foreign invaders. Immunomodulators are substances such as German chamomile and plant sterols, which help strengthen a weak immune system and calm the immune system that are too fragile. Why LDN is effective in MS and other autoimmune diseases low dose naltrexone works to modulate the immune system and helps the body heal itself. By increasing production of endorphins, which act as neurotransmitters, modulating immune function, low doses of naltrexone helps the body return to a state of homeostasis and heal itself. Instead, overactive, immune cells in autoimmune diseases is weak and ineffective. This forces them to act erratically, targeting proteins such as cellular components, they are usually recognized as benign. By strengthening, rather than stimulate the immune system, its cells can restore its normal function of protecting the body against infectious agents and toxins and stop abnormal cell growth. B ™ |
b © May 18 2008Copyrighted Elaine Moore
No comments:
Post a Comment